Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 18;25(18):4294.
doi: 10.3390/molecules25184294.

Tabebuia impetiginosa: A Comprehensive Review on Traditional Uses, Phytochemistry, and Immunopharmacological Properties

Affiliations
Review

Tabebuia impetiginosa: A Comprehensive Review on Traditional Uses, Phytochemistry, and Immunopharmacological Properties

Jianmei Zhang et al. Molecules. .

Abstract

Tabebuia impetiginosa, a plant native to the Amazon rainforest and other parts of Latin America, is traditionally used for treating fever, malaria, bacterial and fungal infections, and skin diseases. Additionally, several categories of phytochemicals and extracts isolated from T. impetiginosa have been studied via various models and displayed pharmacological activities. This review aims to uncover and summarize the research concerning T. impetiginosa, particularly its traditional uses, phytochemistry, and immunopharmacological activity, as well as to provide guidance for future research. A comprehensive search of the published literature was conducted to locate original publications pertaining to T. impetiginosa up to June 2020. The main inquiry used the following keywords in various combinations in titles and abstracts: T. impetiginosa, Taheebo, traditional uses, phytochemistry, immunopharmacological, anti-inflammatory activity. Immunopharmacological activity described in this paper includes its anti-inflammatory, anti-allergic, anti-autoimmune, and anti-cancer properties. Particularly, T. impetiginosa has a strong effect on anti-inflammatory activity. This paper also describes the target pathway underlying how T. impetiginosa inhibits the inflammatory response. The need for further investigation to identify other pharmacological activities as well as the exact target proteins of T. impetiginosa was also highlighted. T. impetiginosa may provide a new strategy for prevention and treatment of many immunological disorders that foster extensive research to identify potential anti-inflammatory and immunomodulatory compounds and fractions as well as to explore the underlying mechanisms of this herb. Further scientific evidence is required for clinical trials on its immunopharmacological effects and safety.

Keywords: Tabebuia impetiginosa; Taheebo; immunological disorders; immunopharmacology; traditional uses.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
Distribution map of Tabebuia impetiginosa.
Figure 2
Figure 2
Chemical structures of Tabebuia impetiginosa-derived components.
Figure 3
Figure 3
Inhibitory targets of Tabebuia impetiginosa in the NF-κB and AP-1 pathways.

References

    1. Ngo L.T., Okogun J.I., Folk W.R. 21st century natural product research and drug development and traditional medicines. Nat. Prod. Rep. 2013;30:584–592. doi: 10.1039/c3np20120a. - DOI - PMC - PubMed
    1. Itokawa H., Morris-Natschke S.L., Akiyama T., Lee K.-H. Plant-derived natural product research aimed at new drug discovery. J. Nat. Med. 2008;62:263–280. doi: 10.1007/s11418-008-0246-z. - DOI - PubMed
    1. Fabricant D.S., Farnsworth N.R. The value of plants used in traditional medicine for drug discovery. Environ. Health Perspect. 2001;109:69–75. - PMC - PubMed
    1. Pires T.C.S.P., Dias M.I., Calhelha R.C., Carvalho A.M., Queiroz M.-J.R., Barros L., Ferreira I.C. Bioactive Properties of Tabebuia impetiginosa-Based Phytopreparations and Phytoformulations: A Comparison between Extracts and Dietary Supplements. Molecules. 2015;20:22863–22871. doi: 10.3390/molecules201219885. - DOI - PMC - PubMed
    1. De Miranda F.G.G., Vilar J.C., Alves I.A.N., Cavalcanti S.C.D.H., Antoniolli Â.R. Antinociceptive and antiedematogenic properties and acute toxicity of Tabebuia avellanedae Lor. ex Griseb. inner bark aqueous extract. BMC Pharmacol. 2001;1:6. doi: 10.1186/1471-2210-1-6. - DOI - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources